KLRS Competitors & Alternatives
Compare Kalaris Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
KLRS
Main Stock$3.90
Tradestie Score
39
Market Cap
$113.52M
Analyst Upside
+379.9%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$19.23
|
$170.45M | - | 55 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$8.49
|
$158.43M | - | 28 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$24.49
|
$154.27M | - | 38 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$15.52
|
$133.50M | - | 43 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.79
|
$114.01M | - | 41 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$35.55
|
$110.20M | - | 42 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.80
|
$97.42M | - | 56 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.00
|
$84.52M | - | 50 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$11.19
|
$71.32M | - | 51 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$13.91
|
$67.94M | - | 38 | Compare |
More KLRS Analysis
Data updated: Sep 06, 2026 | Industry: Biotechnology (SIC 2836)
238 stocks in this industry